Showing results 1 to 5 of 5
-
Han, Sehyeon
;
-
Jang, Soyoung
;
-
Lee, Seoung-Woo
;
-
Kim, Hee-Yeon
;
-
Kim, Wansoo
;
-
Kim, Hyeon-Gyeom
;
-
Park, Jin-Kyu
;
-
Han, Jee Eun
;
-
Ryoo, Zae Young
;
-
Seah, Ethan
;
et al
- 2024-07
- Han, Sehyeon. (2024-07). hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway. Anticancer Research, 44(7), 2847–2859. doi: 10.21873/anticanres.17097
- International Institute of Anticancer Research
- View : 152
- Download : 0
-
Kim, Wansoo
;
-
Yeo, Dong-Yeop
;
-
Choi, Seong-Kyoon
;
-
Kim, Hee-Yeon
;
-
Lee, Seoung-Woo
;
-
Ashim, Janbolat
;
-
Han, Jee Eun
;
-
Yu, Wookyung
;
-
Jeong, Hyohoon
;
-
Park, Jin-Kyu
;
et al
- 2022-12
- Kim, Wansoo. (2022-12). NOLC1 knockdown suppresses prostate cancer progressions by reducing AKT phosphorylation and β-catenin accumulation. Biochemical and Biophysical Research Communications, 635, 99–107. doi: 10.1016/j.bbrc.2022.10.038
- Academic Press
- View : 507
- Download : 0
- 2021-10
- Kim , Daehyun. (2021-10). PMP(Porphyrin-micelle-psma) nanoparticles for photoacoustic and ultrasound signal amplification in mouse prostate cancer xenografts. Pharmaceutics, 13(10). doi: 10.3390/pharmaceutics13101636
- MDPI
- View : 476
- Download : 0
-
Park, Song
;
-
Kwon, Wookbong
;
-
Park, Jin-Kyu
;
-
Baek, Su-Min
;
-
Lee, Seoung-Woo
;
-
Cho, Gil-Jae
;
-
Ha, Yun-Sok
;
-
Lee, Jun Nyung
;
-
Kwon, Tae Gyun
;
-
Kim, Myoung Ok
;
et al
- 2020-07
- Park, Song. (2020-07). Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer. doi: 10.1016/j.abb.2020.108407
- Academic Press
- View : 587
- Download : 0
-
Kwon, Wookbong
;
-
Choi, Seong-Kyoon
;
-
Kim, Daehwan
;
-
Kim, Hyeon-Gyeom
;
-
Park, Jin-Kyu
;
-
Han, Jee Eun
;
-
Cho, Gil-Jae
;
-
Yun, Sungho
;
-
Yu, Wookyung
;
-
Han, Se-Hyeon
;
et al
- 2021-09
- Kwon, Wookbong. (2021-09). ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state. Journal of Experimental & Clinical Cancer Research, 40(1). doi: 10.1186/s13046-021-02094-3
- Springer Science and Business Media LLC
- View : 535
- Download : 158
1